Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions

P Sharma, VE Holmes, R Elsby, C Lambert, D Surry - Xenobiotica, 2010 - Taylor & Francis
Transporters are carrier proteins that may influence pharmacokinetic, pharmacodynamic,
and toxicological characteristics of drugs. The development of validated in vitro transporter …

Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions

S Izumi, Y Nozaki, K Maeda, T Komori… - Drug Metabolism and …, 2015 - ASPET
The risk assessment of organic anion transporting polypeptide (OATP) 1B1–mediated drug-
drug interactions (DDIs) is an indispensable part of drug development. We previously …

Changes in organic anion transporting polypeptide uptake in HEK293 overexpressing cells in the presence and absence of human plasma

CM Bowman, E Chen, L Chen, YC Chen, X Liang… - Drug Metabolism and …, 2020 - ASPET
Generating accurate in vitro data is crucial for in vitro to in vivo extrapolation and
pharmacokinetic predictions. The use of human embryonic kidney (HEK) 293 cells …

Prediction of the in vivo OATP1B1-mediated drug–drug interaction potential of an investigational drug against a range of statins

P Sharma, CJ Butters, V Smith, R Elsby… - European journal of …, 2012 - Elsevier
To support drug development, the drug–drug interaction potential (DDI) of an investigational
drug (AZX) was assessed against the probe estradiol 17β-glucuronide as well as against …

Preincubation Time-Dependent, Long-Lasting Inhibition of Drug Transporters and Impact on the Prediction of Drug− Drug Interactions

Y Nozaki, S Izumi - Drug Metabolism and Disposition, 2023 - ASPET
Transporter-mediated drug− drug interaction (DDI) is of clinical concern, and the quantitative
prediction of DDIs is an indispensable part of drug development. Cell-based inhibition …

Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide …

S Izumi, Y Nozaki, T Komori, K Maeda… - Drug Metabolism and …, 2013 - ASPET
Organic anion transporting polypeptide (OATP) 1B1 plays an important role in the hepatic
uptake of many drugs, and the evaluation of OATP1B1-mediated drug-drug interactions …

Quantitative prediction of human renal clearance and drug-drug interactions of organic anion transporter substrates using in vitro transport data: a relative activity …

S Mathialagan, MA Piotrowski, DA Tess, B Feng… - Drug Metabolism and …, 2017 - ASPET
Organic anion transporters (OATs) are important in the renal secretion, and thus, the
clearance, of many drugs; and their functional change can result in pharmacokinetic …

Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion …

Y Nozaki, S Izumi - Drug Metabolism and Pharmacokinetics, 2020 - Elsevier
Hepatic uptake mediated by organic anion transporting polypeptide (OATP) 1B1 and 1B3
can serve as a major elimination pathway for various anionic drugs and as a site of drug …

Meta-analysis of expression of hepatic organic anion–transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue

J Badée, B Achour, A Rostami-Hodjegan… - Drug Metabolism and …, 2015 - ASPET
Organic anion–transporting polypeptide (OATP) 1B1, OATP1B3, and OATP2B1 transporters
play an important role in hepatic drug disposition. Recently, an increasing number of studies …

Experimental and modeling evidence supporting the trans-inhibition mechanism for preincubation time-dependent, long-lasting inhibition of organic anion transporting …

S Izumi, Y Nozaki, W Lee, Y Sugiyama - Drug Metabolism and Disposition, 2022 - ASPET
Cyclosporine A (CsA) and rifampin are potent inhibitors of organic anion transporting
polypeptide (OATP) 1B1 and are widely used to assess the risk for drug-drug interactions …